| Net Cash Provided by (Used in) Operating Activities |
$4,477,000 |
USD |
-29% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$10,250,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,760,000 |
USD |
-4173% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
40,117,404 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,013,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,436,000 |
USD |
82% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$17,378,400 |
USD |
34% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$17,401,300 |
USD |
35% |
Q4 2025 |
FY 2025 |
| Depreciation |
$7,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$11,132,100 |
USD |
49% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$357,900 |
USD |
25% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$79,887,000 |
USD |
38% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$5,146,893 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |